# Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents

Study · id `cardio:ct-nct02508714` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02508714](<https://clinicaltrials.gov/study/NCT02508714>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02508714

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 2470 participants.

## Technical summary

Registry record NCT02508714. Randomized; double masking; primary purpose treatment. Start 2016-10-07 (actual); primary completion 2018-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2470 participants (enrolled count; ClinicalTrials.gov record NCT02508714, source copy `cardio:ctgov-nct02508714-2017-02-03`, retrieved 2026-10-26)
- Started: 2016-10-07 (actual) (ClinicalTrials.gov record NCT02508714, source copy `cardio:ctgov-nct02508714-2017-02-03`, retrieved 2026-10-26)
- Primary completion: 2018-03 (anticipated) (ClinicalTrials.gov record NCT02508714, source copy `cardio:ctgov-nct02508714-2017-02-03`, retrieved 2026-10-26)
- Completion: 2019-03 (anticipated) (ClinicalTrials.gov record NCT02508714, source copy `cardio:ctgov-nct02508714-2017-02-03`, retrieved 2026-10-26)
- Countries: Belgium; Israel; Netherlands (ClinicalTrials.gov record NCT02508714, source copy `cardio:ctgov-nct02508714-2017-02-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02508714-2017-02-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
- Acronym: BIONYX
- Condition: Coronary Artery Disease
- Condition: Angina Pectoris
- Condition: Unstable Angina Pectoris
- Condition: Acute Coronary Syndrome
- Condition: Coronary Stenosis
- Condition: Coronary Restenosis
- Intervention (Device): Orsiro
- Intervention (Device): Resolute Onyx
- Lead sponsor: Thorax Centrum Twente
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial (`cardio:pubmed-30253879`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial (`cardio:pubmed-34261828`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent (`cardio:pubmed-38713843`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-up (`cardio:pubmed-40035811`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7cd79b85e6c682c5a65d47696119eec874f711d2e379e6430b1bbbe954482086
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
